IPOGrid
0001811623
IPO filing research

Kuvatris Therapeutics, Inc.

Pharmaceutical Preparations

follow-on effective EFFECT

Kuvatris Therapeutics, Inc. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: EFFECT on 2024-10-15.

Filing Timeline

SEC EDGAR
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
2024-10-15 · 9999999995-24-003189
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B4 in the pre-IPO sequence.
2024-10-03 · 0001493152-24-039370
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2023-11-21 · 0001104659-23-120134
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2023-11-20 · 9999999995-23-003393
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2023-11-16 · 0001104659-23-119135
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS in the pre-IPO sequence.
2023-11-09 · 0001104659-23-115933
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
Begins the tracked draft filing sequence after EFFECT.
2023-08-10 · 0001104659-23-089880
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2023-05-11 · 9999999995-23-001396
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-1 and confirms the priced prospectus.
2023-05-11 · 0001104659-23-059233
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
2023-05-04 · 0001104659-23-055679
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2023-04-07 · 0001104659-23-043144
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2023-04-05 · 9999999995-23-000832
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2023-02-15 · 0001104659-23-022449
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2023-02-07 · 0001104659-23-011543
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2023-01-06 · 0001104659-23-001862
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2022-12-27 · 9999999995-22-003648
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-1 and confirms the priced prospectus.
2022-12-27 · 0001104659-22-130194
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B4 in the pre-IPO sequence.
2022-12-19 · 0001104659-22-128262
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2022-08-29 · 0001104659-22-095618
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows CERT and marks the registration effective.
2022-08-12 · 9999999995-22-002356
CERT inactive
CERT
Pre-IPO filing captured from the SEC submission timeline.
Follows 8-A12B in the pre-IPO sequence.
2022-08-12 · 0001354457-22-000463
8-A12B effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows S-1/A and registers the class of securities for exchange listing.
2022-08-10 · 0001104659-22-088584
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2022-08-10 · 0001104659-22-088197
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2022-08-08 · 0001104659-22-087163
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2022-07-19 · 0001104659-22-080619
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2022-06-10 · 0001104659-22-070160
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2022-01-04 · 0001104659-22-000980
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2020-09-29 · 0001104659-20-109530
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2020-09-15 · 0001104659-20-105289
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2020-09-14 · 0001104659-20-104871
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior FWP filing.
2020-09-02 · 0001104659-20-101866
FWP supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows S-1/A and supplements the active offering with updated prospectus details.
2020-08-28 · 0001104659-20-099809
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2020-08-28 · 0001104659-20-099715
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2020-07-23 · 0001104659-20-086036
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS in the pre-IPO sequence.
2020-07-02 · 0001104659-20-080656
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
2020-05-15 · 0001104659-20-062764
Comparable Deals

20 comparable deals

Healthcare & BiotechLast 18 months
Only 0 strict matches; expanded to 20 using nearest neighbors.
Showing top 8 by similarity.
+9.1%
Median day-1
60%
Above issue
+0.7%
Median week-1
-20.9%
Downside (p10)
BlossomHill Therapeutics, Inc. BLSM
2026-08-07 $150M Day 1: +0.0% Wk 1: +0.0%
same SICrecent IPO
Latigo Biotherapeutics, Inc. LTGO
2026-08-07 $346M Day 1: +1.4% Wk 1: +1.4%
same SICrecent IPO
Braveheart Bio, Inc. BRVE
2026-08-06 $383M Day 1: +65.6% Wk 1: +66.7%
same SICrecent IPO
Apnimed, Inc. APMD
2026-07-31 $192M Day 1: +43.6% Wk 1: +74.3%
same SICrecent IPO
Kardigan, Inc. KARD
2026-06-18 $400M Day 1: +37.5% Wk 1: +41.1%
same SICrecent IPO
Parabilis Medicines, Inc. PBLS
2026-06-10 $670M Day 1: +58.0% Wk 1: +30.2%
same SICrecent IPO
Seaport Therapeutics, Inc. SPTX
2026-05-01 $255M Day 1: +10.2% Wk 1: -13.9%
same SICrecent IPO
Avalyn Pharma Inc. AVLN
2026-04-30 $300M Day 1: +63.8% Wk 1: +53.9%
same SICrecent IPO

Recent News

No recent news stored for this issuer.